Photodynamic therapy with the preparation Visudyne in macular degeneration with subfoveal, predominantly classic choroidal neovascularization;Fotodynamická terapie s preparátem Visudyne u makulární degenerace se subfoveolárně uloženou převážně klasickou choroidální neovaskularizací

Ceska a Slovenska Oftalmologie

Volumn 58, Issue 2, 2002, Pages 89-97

  Souček, Petr ^a   Boguzsakova J ^a   Cihelkova I ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Digital imaging system; Myopia; Photodynamic therapy; Verteporfin; Visudyne

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MALE; PHOTODYNAMIC THERAPY; RETINA FOVEA; RETINA MACULA DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS;

EID: 0036229555     PISSN: 12119059     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Photodynamic therapy with verteporfin (Visudyne): Impact on ophthalmology and visual sciences
2. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: The influence of initial lesion size and initial visual acuity
3. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of a single treatment in a phase 1 and 2 study
4. Photodynamic therapy of subfoveal choroidal neovascularization: Clinical and angiographic examples
5. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of retreatment in a phase 1 and 2 study
6. Mechanismus of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration
7. Early detection, diagnosis and management of choroidal neovascularization in age-related macular degeneration: The role of ophthalmologists
8. Treatment of subfoveal choroidal neovascularization in age related macular degeneration: Focus on clinical application of verteporfin photodynamic therapy
9. Diagnostika, sledování a laserová léčba klasické formy chorioideální neovaskularizace u pacientů s věkem podmíněnou makulární degenerací
10. Laserová terapie věkem podmíněné makulární degenerace, poznámky pro klinickou praxi
11. Combining photodynamic therapy and feeder vessel photocoagulation: A pilot study
12. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials - TAP report 1
13. Photodynamic therapy ofsubfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: Two-year results of 2 randomized clinical trials - TAP report 2
14. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfm: 1-Year results of a randomized clinical trial - VIP report no. 1
15. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2